Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

research Early onset androgenic alopecia: not a cosmetic problem but a sign of life time risk factors. Male phenotypic equivalent of polycystic ovarian syndrome: Is There a Male Phenotype of PCOS

April 2021 in “Medical Science and Discovery”

Early hair loss in men may signal broader health issues similar to PCOS in women.

Early Onset Androgenic Alopecia as the Male Phenotypic Equivalent of Polycystic Ovarian Syndrome Is Associated with High Oxidative Stress

research Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress

January 2021 in “Medicine Science | International Medical Journal”

Men with early hair loss may have higher health risks similar to women with PCOS.

research Androgenic alopecia associated with the HSD3B1 (1245a>c) in overweight women with polycystic ovarian syndrome

September 2018 in “Fertility and Sterility”

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

research S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma

32 citations , August 2020 in “American Journal Of Pathology”

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

research Does a male polycystic ovarian syndrome equivalent exist?

28 citations , July 2017 in “Journal of Endocrinological Investigation”

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Optimized Polycystic Ovarian Disease Prognosis and Classification Using AI-Based Computational Approaches on Multi-Modality Data

research Optimized polycystic ovarian disease prognosis and classification using AI based computational approaches on multi-modality data

19 citations , October 2024 in “BMC Medical Informatics and Decision Making”

AI can improve early diagnosis and classification of PCOS, aiding in prevention of related health issues.

research Long-Term Suppression of Testosterone After Treatment with a Gonadotropin-Releasing Hormone Agonist in a Woman with a Presumed Testosterone Secreting Ovarian Tumor

19 citations , June 1997 in “The Journal of Clinical Endocrinology & Metabolism”

The treatment successfully lowered testosterone levels and reduced symptoms.

research Male Equivalent Polycystic Ovarian Syndrome: Hormonal, Metabolic, and Clinical Aspects.

12 citations , July 2020 in “DOAJ (DOAJ: Directory of Open Access Journals)”

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

research New potential chemotherapy for ovarian cancer — Combined therapy with WP 631 and epothilone B

12 citations , March 2016 in “Life Sciences”

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

research COVID-19 in Africa: an ovarian victory?

11 citations , May 2021 in “Journal of Ovarian Research”

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

← Previous page